Jiangsu Apon Medical Technology Co., Ltd.
Symbol: 300753.SZ
SHZ
12.98
CNYTržní cena dnes
-103.9099
Poměr P/E
0.0000
Poměr PEG
1.64B
MRK Cap
- 0.00%
Výnos DIV
Jiangsu Apon Medical Technology Co., Ltd. (300753-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 249.3 | 274.7 | 388.6 | |||||||||
balance-sheet.row.short-term-investments | 0 | -22.7 | -7.6 | -1.5 | |||||||||
balance-sheet.row.net-receivables | 0 | 133.6 | 139.2 | 102.3 | |||||||||
balance-sheet.row.inventory | 0 | 61 | 67.4 | 31.7 | |||||||||
balance-sheet.row.other-current-assets | 0 | 1.5 | 2.9 | 0.7 | |||||||||
balance-sheet.row.total-current-assets | 0 | 445.4 | 484.2 | 523.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 207 | 212.8 | 168.6 | |||||||||
balance-sheet.row.goodwill | 0 | 53.2 | 69.4 | 33.9 | |||||||||
balance-sheet.row.intangible-assets | 0 | 35.6 | 33.2 | 37.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 88.8 | 102.6 | 71.6 | |||||||||
balance-sheet.row.long-term-investments | 0 | 103.8 | 87 | 60.5 | |||||||||
balance-sheet.row.tax-assets | 0 | 24.4 | 8.7 | 2.1 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.8 | 3.7 | 1.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 424.8 | 414.9 | 303.9 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.account-payables | 0 | 46.9 | 27.8 | 31.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 33.8 | 2 | -3.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 6.6 | 8.5 | 14.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 34.5 | 39.9 | 3.7 | |||||||||
Deferred Revenue Non Current | 0 | 1.9 | 2 | 2 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 1.6 | 42.3 | 53.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 36.7 | 42 | 2.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 34.5 | 39.9 | 3.7 | |||||||||
balance-sheet.row.total-liab | 0 | 183.9 | 118.5 | 87.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 126 | 126 | 105 | |||||||||
balance-sheet.row.retained-earnings | 0 | 188.1 | 264.5 | 247.1 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 41.5 | 41.5 | 36.5 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 329.9 | 347.6 | 350.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 685.6 | 779.6 | 739.5 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.minority-interest | 0 | 0.8 | 0.9 | 0.3 | |||||||||
balance-sheet.row.total-equity | 0 | 686.4 | 780.5 | 739.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 81.1 | 79.4 | 59 | |||||||||
balance-sheet.row.total-debt | 0 | 68.4 | 39.9 | 3.7 | |||||||||
balance-sheet.row.net-debt | 0 | -180.9 | -234.8 | -384.8 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -76.5 | 53.3 | 96.9 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 15.5 | 6.6 | -0.7 | |||||||||
cash-flows.row.change-in-working-capital | 0 | 28.3 | -76.7 | -25.8 | |||||||||
cash-flows.row.account-receivables | 0 | 9.1 | -47.6 | -34 | |||||||||
cash-flows.row.inventory | 0 | 6.3 | -33.6 | -3.3 | |||||||||
cash-flows.row.account-payables | 0 | 28.4 | 11.1 | 10.7 | |||||||||
cash-flows.row.other-working-capital | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.other-non-cash-items | 0 | 4.1 | 26.3 | 2.6 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.acquisitions-net | 0 | 0.1 | -37.3 | 2.7 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -3 | -22.5 | -52.4 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 0.1 | 0.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | -256.7 | 2.5 | 1.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -24.8 | -96.7 | -83.1 | |||||||||
cash-flows.row.debt-repayment | 0 | -29.4 | 0 | -0.4 | |||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | -0.6 | -31.5 | -32.3 | |||||||||
cash-flows.row.other-financing-activites | 0 | 54 | -4.3 | 0.4 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 23.9 | -35.8 | -32.3 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -25.5 | -114.3 | -32 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 248.8 | 274.3 | 388.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 274.3 | 388.6 | 420.6 | |||||||||
cash-flows.row.operating-cash-flow | 0 | -24.6 | 18.3 | 83.3 | |||||||||
cash-flows.row.capital-expenditure | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.free-cash-flow | 0 | -48.8 | -21.3 | 47.7 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 323.8 | 461.2 | 443.1 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 163.8 | 166.3 | 188.6 | |||||||||
income-statement-row.row.gross-profit | 0 | 160 | 294.9 | 254.5 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.operating-expenses | 0 | 232 | 235.5 | 146.3 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 395.7 | 401.8 | 334.9 | |||||||||
income-statement-row.row.interest-income | 0 | 2.1 | 3.6 | 7.2 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | -88.3 | 55.8 | 113.5 | |||||||||
income-statement-row.row.income-before-tax | 0 | -90.7 | 55.3 | 111.9 | |||||||||
income-statement-row.row.income-tax-expense | 0 | -14.2 | 2 | 15 | |||||||||
income-statement-row.row.net-income | 0 | -76.4 | 54.1 | 97 |
Často kladené otázky
Co je Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) celková aktiva?
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) celková aktiva jsou 870213234.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.567.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -0.266.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je -0.043.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou -0.061.
Co je Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -76377405.540.
Jaký je celkový dluh podniku?
Celkový dluh je 68373296.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 231973871.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.